Region | Countries with GF-supported DOTS programme | Case detections in GF-supported DOTS programmes | Estimate d treatments completed | Cumulative lives saved (95% UR) | |||
---|---|---|---|---|---|---|---|
Counterfactual scenario: | Counterfactual scenario: | ||||||
No treatment | Non-DOTS treatment | ||||||
East Africa | 7 | 448,243 | 363,794 | 223,574 | (128,704-318,445) | 76,019 | (42,182-109,856) |
Western Africa | 10 | 109,806 | 87,668 | 53,692 | (31,794-75,591) | 18,205 | (10,396-26,015) |
Southern Africa | 6 | 239,144 | 208,153 | 133,546 | (75,230-191,862) | 46,957 | (25,593-68,320) |
North Africa & Middle East | 9 | 68,195 | 45,438 | 26,634 | (15,708-37,560) | 6,342 | (2,912-9,772) |
Eastern Europe & Central Asia | 10 | 72,345 | 53,023 | 26,125 | (15,558-36,691) | 1,530 | (370-2,690) |
South Asia | 7 | 554,726 | 382,333 | 230,612 | (133,671-327,553) | 75,654 | (41,271-110,037) |
East Asia and the Pacific | 9 | 1,774,876 | 1,524,979 | 916,232 | (541,056-1,291,408) | 180,256 | (94,065-266,448) |
Latin America & Caribbean | 10 | 44,926 | 35,418 | 21,205 | (12,588-29,823) | 3,182 | (1,620-4,743) |
Total | 68 | 3,312,261 | 2,700,805 | 1,632,000 | 408,000 | ||
95% Uncertainty range | (3,211,843 -3,412,679) | (2,618,925 -2,782,685) | (1,094,000-2,169,000) | (265,000-551,000) |